Radiosensitizing potential of Plumbagin in B16F1 melanoma tumor cells through mitochondrial mediated programmed cell death

Bola Sadashiva Satish Rao, Mandala Rayabandla Sunil Kumar, Shubhankar Das, Kiran Aithal, Nayanabhirama Udupa

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The radiosensitizing potential of Plumbagin (PLB) against chemo- and radioresistant B16F1 melanoma cells growing in vitro was investigated. Clonogenic assay revealed a sensitization enhancement ratio (SER) of 1.5 for PLB treatment in combination with radiation. PLB pretreatment for 1 h prior to radiation resulted in elevated intracellular ROS levels compared to the group treated with radiation alone. Alkaline comet assay analysis revealed PLB's potential to enhance the radiation induced DNA damage. Cell cycle studies have shown enhanced G2/M arrest for combination treatment of PLB with radiation. Cell death exerted by PLB combination was mainly through programmed cell death, involving the depletion of mitochondrial membrane potential, increase in the expression of p53, Bax, Cytochrome c, PARP and Caspase 3 cleavage. In conclusion, this study demonstrates the radiosensitizing potential of PLB to inhibit the growth of melanoma cells in vitro, which may be attributed to the oxidative stress and DNA damage leading to enhanced mitochondria-mediated programmed cell death. Also, this study demonstrate the ability of PLB to augment ionizing radiation induced tumor cell kill which further warrant the avenue for the development of a clinically useful radiosensitizer.

Original languageEnglish
Pages (from-to)279-288
Number of pages10
JournalJournal of Applied Biomedicine
Volume13
Issue number4
DOIs
Publication statusPublished - 01-11-2015

Fingerprint

plumbagin
Cell death
melanoma
Tumors
Melanoma
Cell Death
apoptosis
Cells
Radiation
Neoplasms
DNA damage
DNA Damage
Assays
Mitochondria
Oxidative stress
Comet Assay
Mitochondrial Membrane Potential
cytochrome c
DNA
Ionizing radiation

All Science Journal Classification (ASJC) codes

  • Neuroscience(all)
  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

@article{ff33d14b2b874e99b575f76340a48d56,
title = "Radiosensitizing potential of Plumbagin in B16F1 melanoma tumor cells through mitochondrial mediated programmed cell death",
abstract = "The radiosensitizing potential of Plumbagin (PLB) against chemo- and radioresistant B16F1 melanoma cells growing in vitro was investigated. Clonogenic assay revealed a sensitization enhancement ratio (SER) of 1.5 for PLB treatment in combination with radiation. PLB pretreatment for 1 h prior to radiation resulted in elevated intracellular ROS levels compared to the group treated with radiation alone. Alkaline comet assay analysis revealed PLB's potential to enhance the radiation induced DNA damage. Cell cycle studies have shown enhanced G2/M arrest for combination treatment of PLB with radiation. Cell death exerted by PLB combination was mainly through programmed cell death, involving the depletion of mitochondrial membrane potential, increase in the expression of p53, Bax, Cytochrome c, PARP and Caspase 3 cleavage. In conclusion, this study demonstrates the radiosensitizing potential of PLB to inhibit the growth of melanoma cells in vitro, which may be attributed to the oxidative stress and DNA damage leading to enhanced mitochondria-mediated programmed cell death. Also, this study demonstrate the ability of PLB to augment ionizing radiation induced tumor cell kill which further warrant the avenue for the development of a clinically useful radiosensitizer.",
author = "{Satish Rao}, {Bola Sadashiva} and {Sunil Kumar}, {Mandala Rayabandla} and Shubhankar Das and Kiran Aithal and Nayanabhirama Udupa",
year = "2015",
month = "11",
day = "1",
doi = "10.1016/j.jab.2015.07.003",
language = "English",
volume = "13",
pages = "279--288",
journal = "Journal of Applied Biomedicine",
issn = "1214-021X",
publisher = "University of South Bohemia",
number = "4",

}

Radiosensitizing potential of Plumbagin in B16F1 melanoma tumor cells through mitochondrial mediated programmed cell death. / Satish Rao, Bola Sadashiva; Sunil Kumar, Mandala Rayabandla; Das, Shubhankar; Aithal, Kiran; Udupa, Nayanabhirama.

In: Journal of Applied Biomedicine, Vol. 13, No. 4, 01.11.2015, p. 279-288.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Radiosensitizing potential of Plumbagin in B16F1 melanoma tumor cells through mitochondrial mediated programmed cell death

AU - Satish Rao, Bola Sadashiva

AU - Sunil Kumar, Mandala Rayabandla

AU - Das, Shubhankar

AU - Aithal, Kiran

AU - Udupa, Nayanabhirama

PY - 2015/11/1

Y1 - 2015/11/1

N2 - The radiosensitizing potential of Plumbagin (PLB) against chemo- and radioresistant B16F1 melanoma cells growing in vitro was investigated. Clonogenic assay revealed a sensitization enhancement ratio (SER) of 1.5 for PLB treatment in combination with radiation. PLB pretreatment for 1 h prior to radiation resulted in elevated intracellular ROS levels compared to the group treated with radiation alone. Alkaline comet assay analysis revealed PLB's potential to enhance the radiation induced DNA damage. Cell cycle studies have shown enhanced G2/M arrest for combination treatment of PLB with radiation. Cell death exerted by PLB combination was mainly through programmed cell death, involving the depletion of mitochondrial membrane potential, increase in the expression of p53, Bax, Cytochrome c, PARP and Caspase 3 cleavage. In conclusion, this study demonstrates the radiosensitizing potential of PLB to inhibit the growth of melanoma cells in vitro, which may be attributed to the oxidative stress and DNA damage leading to enhanced mitochondria-mediated programmed cell death. Also, this study demonstrate the ability of PLB to augment ionizing radiation induced tumor cell kill which further warrant the avenue for the development of a clinically useful radiosensitizer.

AB - The radiosensitizing potential of Plumbagin (PLB) against chemo- and radioresistant B16F1 melanoma cells growing in vitro was investigated. Clonogenic assay revealed a sensitization enhancement ratio (SER) of 1.5 for PLB treatment in combination with radiation. PLB pretreatment for 1 h prior to radiation resulted in elevated intracellular ROS levels compared to the group treated with radiation alone. Alkaline comet assay analysis revealed PLB's potential to enhance the radiation induced DNA damage. Cell cycle studies have shown enhanced G2/M arrest for combination treatment of PLB with radiation. Cell death exerted by PLB combination was mainly through programmed cell death, involving the depletion of mitochondrial membrane potential, increase in the expression of p53, Bax, Cytochrome c, PARP and Caspase 3 cleavage. In conclusion, this study demonstrates the radiosensitizing potential of PLB to inhibit the growth of melanoma cells in vitro, which may be attributed to the oxidative stress and DNA damage leading to enhanced mitochondria-mediated programmed cell death. Also, this study demonstrate the ability of PLB to augment ionizing radiation induced tumor cell kill which further warrant the avenue for the development of a clinically useful radiosensitizer.

UR - http://www.scopus.com/inward/record.url?scp=84969630988&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84969630988&partnerID=8YFLogxK

U2 - 10.1016/j.jab.2015.07.003

DO - 10.1016/j.jab.2015.07.003

M3 - Article

AN - SCOPUS:84969630988

VL - 13

SP - 279

EP - 288

JO - Journal of Applied Biomedicine

JF - Journal of Applied Biomedicine

SN - 1214-021X

IS - 4

ER -